Data Foundry

Drug recalls 2019

Losartan Potassium / Hydrochlorothiazide Tablets — Class II drug recall D-1119-2019

Ongoing recall by Torrent Pharma Inc., reported 2019-04-17, distributed nationwide. CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished

Recall numberD-1119-2019
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmTorrent Pharma Inc., Basking Ridge, NJ, United States
Recall initiated2019-02-28
Classified2019-04-10
Reported by FDA2019-04-17
DistributedNationwide (US)
Quantity173,760 bottles
Reason classescgmp, specification failure
NDC13668-0118-10, 13668-0118-30, 13668-0118-90
Lot numbers4P04E003, 4P04E004, 4P04E005, 4P04E006, 4P04E007, 4P04E008, 4P04E009, BEF6D030, BEF6D031, BEF6D038, BEF6D047, BEF6D048, BEF6D049, BEF6D050, BEF6D051, BEF6D082, BEF6D083, BEF6D084, BEF6D085, BEF6D086, BEF6D087
Expiration dates2020-04-30, 2020-07-31, 2020-10-31, 2021-01-31

Product

Losartan Potassium / Hydrochlorothiazide Tablets, USP 100mg/25mg, a) 30-count (NDC: 13668-118-30), b) 90-count (NDC: 13668-118-90), c) 1000-count (NDC: 13668-118-10) per bottle , Rx only, Manufactured by: Torrent Pharmaceuticals LTD, Indrad-382 721, Dist. Mehsana India. For: Torrent Pharma, Inc, 150 Allen Road, Suite 102, Basking Ridge, NJ

Reason for recall

CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1119-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.